• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brooks Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40505.0
  • ISIN : INE650L01011
151.64 3 (2.00%)
  • As on 12 Jul 2025 (EOD)

  • Today’s Low

    151.64

  • Today’s High

    151.64

  • Open

    151.64

  • Perv Close

    148.67

  • 52W Low

    82.00

  • 52W High

    198.86

Key Indicators

  • P/E(TTM)

    142.36

  • Mar.Cap (₹Cr.)

    446.69

  • Div & Yield %

    0.00

  • Book Value(₹)

    39.06

  • Debt-Equity Ratio

    2.00

  • AGM Date

    11-Jul-2025

  • EPS

    1.04

  • P/E Ratio

    142.36

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    446.69

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    29.46

  • BV (₹)

    39.10

  • Sales( ₹ in Cr.)

    82.56

  • NP (in Cr.)

    3.05

  • NP Var(%)

    101.0

  • Div%

    0.0

  • CPS (₹)

    1.60

  • EPS (₹)

    1.00

  • Traded Value (₹ in Lakhs)

    436.11

  • 52 Week High

    198.86

  • 52 Week Low

    82.00

  • Price BSE

    148.0

  • Price NSE

    152.00

  • Market Capital( in Cr.)

    436.11

  • P/C Ratio

    93.70

  • P/E Ratio

    142.80

  • Price Vs.BV

    1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 79.49 55.54 76.97 77.27 69.69 55.03
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 79.49 55.54 76.97 77.27 69.69 55.03
Other Income 0.96 0.12 0.95 0.96 0.41 2.88
Stock Adjustments -1.40 -2.01 2.93 3.34 3.29 1.14
Total Income 79.05 53.65 80.85 81.57 73.39 59.05
EXPENDITURE :            
Raw Materials 56.59 39.48 53.59 52.56 50.13 40.57
Power and Fuel Cost 1.73 1.58 1.64 2.70 2.90 2.56
Employee Cost 10.09 10.65 10.88 12.04 11.16 10.04
Other Manufacturing Expenses 1.34 1.22 3.77 3.17 3.75 3.45
Selling and Administration Expenses 4.05 4.91 6.39 6.57 5.88 4.86
Miscellaneous Expenses 1.07 1.50 1.75 2.63 3.08 3.05
Employee Benefit Expenses 10.09 10.65 10.88 12.04 11.16 10.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 74.87 59.34 78.02 79.67 76.90 64.53
Operating Profit 4.17 -5.70 2.82 1.91 -3.52 -5.49
Interest 0.84 0.77 0.67 3.25 3.35 2.96
Gross Profit 3.33 -6.47 2.15 -1.34 -6.87 -8.45
Depreciation 1.77 1.72 1.49 7.09 6.65 6.50
Profit Before Tax 1.56 -8.19 0.66 -8.43 -13.52 -14.95
Current Tax 0.03 0.00 0.00 7.15 9.12 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 1.74 -0.14
Reported Net Profit 1.53 -8.18 0.67 -15.59 -24.38 -14.81
Extraordinary Items 0.01 0.01 0.26 -0.06 -1.18 0.17
Adjusted Net Profit 1.52 -8.19 0.41 -15.53 -23.20 -14.98
Adjustment below Net Profit 0.00 0.00 0.00 -18.73 -0.05 0.00
P & L Balance brought forward -36.30 -28.12 -28.79 5.53 29.96 44.76
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -34.78 -36.30 -28.12 -28.79 5.53 29.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.58 -3.31 0.27 -6.31 -9.87 0.00
Earnings Per Share(Adj)-Unit Curr 0.58 -3.28 0.27 -6.25 -9.77 0.00
Book Value 26.49 22.98 26.31 25.99 39.84 64.96
Book Value(Adj)-Unit Curr 26.49 22.76 26.06 25.74 39.45 53.64

Shareholding Pattern

  • Promoter Group

    52.62%

  • Public Share Holding

    47.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,500,292 52.62 15,500,292 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,500,292 52.62 15,500,292 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,916,111 9.90 2,916,111 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 141,340 0.48 141,340 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,057,451 10.38 3,057,451 2
2] Non Institution
Bodies Corporate 977,700 3.32 977,700 65
Clearing Members 4,460 0.02 4,460 2
Directors of their Relatives 100 0.00 100 1
Employees 1,865 0.01 537 7
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 142,259 0.48 142,259 133
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 344,251 1.17 344,251 233
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,216,220 14.31 4,216,220 66
Individuals holding nominal share capital up to Rs. 1 lakh 5,212,650 17.70 5,212,278 9,800
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,899,505 37.00 10,897,805 10,307
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 29,457,248 100.00 29,455,548 10,317

Company Background

Brooks Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Brooks Laboratories Ltd
  • BSE Code : 40505.0
  • ISIN : INE650L01011

  • Incorporation Year

    2002

  • Registered Office

    Village Kishanpura
    Nilagarh Road Baddi, Solan,
    Himachal Pradesh-174101

  • Telephone

    91-1795-654001/02/03

  • FAX

    91-1795-236939

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    DMKH & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Brooks Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brooks Lab. 148.05 80.44 79.49 142.36 2.72
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10